Pixium Vision presents at Ophta Biotech, annual conference on ophthalmic innovationsadmin2019-09-11T17:33:28+02:00February 11th, 2015|
Pixium Vision’s governance evolves to prepare the launch of IRIS®admin2019-09-11T17:33:56+02:00February 11th, 2015|
Pixium Vision présente ses systèmes de vision bionique au congrès Vision Innovation dédié aux innovations en faveur de la malvoyanceadmin2019-09-11T17:33:27+02:00February 8th, 2015|
GenSight Biologics, Pixium Vision and Fondation Voir et Entendre join forces and benefit from a total €18.5 million funding for SIGHT AGAIN as part of the Investment for the Futureadmin2019-09-11T17:33:57+02:00January 26th, 2015|
Pixium Vision to receive up to €6.9 million in new financing from the SIGHT AGAIN public-private project against blindnessadmin2019-09-11T17:33:40+02:00January 26th, 2015|
Pixium Vision: sales for the first 9 months of 2014admin2019-09-11T17:34:01+02:00November 14th, 2014|
Pixium Vision to attend the Large and Midcap Event investors conference in Parisadmin2019-09-11T17:33:28+02:00September 30th, 2014|
Pixium Vision to attend the Goldman Sachs European MedTech and Healthcare Services conferenceadmin2019-09-11T17:33:57+02:00August 28th, 2014|
Pixium Vision financial results for the first half of 2014admin2019-09-11T17:33:57+02:00July 30th, 2014|
Pixium Vision implements a liquidity agreement with Gilbert Dupontadmin2019-09-11T17:33:59+02:00July 17th, 2014|
Pixium Vision announces successful completion of its IPO with its overallotment option exercised at 95.8%admin2019-09-11T17:34:00+02:00July 17th, 2014|
